Package Leaflet: Information for the User
Lansoprazole Sun 15 mg Orally Disintegrating Tablets EFG
Lansoprazole Sun 30 mg Orally Disintegrating Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance of Lansoprazole Sun is lansoprazole, a proton pump inhibitor. Proton pump inhibitors reduce the amount of acid produced by the stomach.
Your doctor may prescribe this medicine for the following indications:
Do not take Lansoprazole Sun
Warnings and precautions
Consult your doctor if you have severe liver disease. Your doctor may need to adjust your dose.
Your doctor may have performed or may perform a complementary test called endoscopy to diagnose your disease and/or rule out a malignant disease.
If you experience severe or persistent diarrhea during treatment with lansoprazole, contact your doctor immediately, as lansoprazole has been associated with a small increase in infectious diarrhea.
If your doctor has prescribed lansoprazole in addition to other medications intended for the treatment of Helicobacter pylori infection (antibiotics) or together with anti-inflammatory medications to treat pain or rheumatic disease: also read the package leaflets of these medications carefully.
If you take lansoprazole for more than three months, it is possible that your blood magnesium levels may decrease. Low magnesium levels can manifest as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, and increased heart rate. If you experience any of these symptoms, inform your doctor immediately. Low magnesium levels can also cause a reduction in blood potassium or calcium levels. Your doctor may decide to perform periodic blood tests to monitor your magnesium levels.
Taking a proton pump inhibitor like lansoprazole, especially for a period of more than one year, may slightly increase the risk of hip, wrist, or spine fractures. Inform your doctor if you have osteoporosis (reduced bone density) or if your doctor has told you that you are at risk of osteoporosis (for example, if you are taking steroids).
This medicine may affect the way your body absorbs vitamin B12, especially if you need to take it for a prolonged period. Contact your doctor if you notice any of the following symptoms, which could indicate low vitamin B12 levels:
If you take lansoprazole for a prolonged period (more than 1 year), your doctor will likely keep you under regular control. You must report any new or exceptional symptoms and circumstances each time you consult your doctor.
Consult your doctor before taking lansoprazole:
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with lansoprazole treatment. Stop using lansoprazole and seek immediate medical attention if you notice any of the symptoms described in section 4.
If you have a skin rash, especially in sun-exposed areas, inform your doctor as soon as possible, as you may need to interrupt your treatment with lansoprazole. Also, mention any other adverse effect such as joint pain.
When taking lansoprazole, kidney inflammation may occur. The signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, rash, and joint stiffness. You should report such signs to your treating doctor.
Other medicines and Lansoprazole Sun
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Especially, tell your doctor or pharmacist if you are using medicines that contain any of the following active substances, as lansoprazole may affect their mode of action:
Taking Lansoprazole Sun with food and drinks
To get the best results from your medicine, you should take lansoprazole at least 30 minutes before meals.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Sometimes side effects such as dizziness, vertigo, fatigue, and visual disturbances occur in patients taking lansoprazole. If you experience side effects like these, you should be careful as your reaction ability may be reduced. You are responsible for deciding whether you are in a fit state to drive a motor vehicle or perform other tasks that require increased attention. Due to its effects or side effects, one of the factors that can reduce your ability to do these things safely is the use of medicines.
The descriptions of these effects can be found in other sections.
Read all the information in this leaflet as a guide.
Talk to your doctor or pharmacist if you are not sure about anything.
Lansoprazole Sun contains aspartame
Each 15 mg Lansoprazole Sun tablet contains 4.5 mg of aspartame.
Each 30 mg Lansoprazole Sun tablet contains 9.0 mg of aspartame.
Aspartame is a source of phenylalanine, which may be harmful in case of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body is unable to eliminate it properly.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Place the tablet on your tongue and suck it slowly. The tablet dissolves quickly in the mouth, releasing microgranules that should be swallowed without chewing. You can also swallow the tablet whole with a glass of water.
If you are taking lansoprazole once a day, try to take it at the same time every day. You may get better results if you take lansoprazole in the morning.
If you are taking lansoprazole twice a day, you should receive the first dose in the morning and the second dose in the evening.
The dose of lansoprazole depends on your disease. The following are the recommended doses of lansoprazole for adults. Your doctor will prescribe a different dose and indicate how long the treatment will last.
Treatment of heartburn and acid regurgitation:one 15 mg or 30 mg orally disintegrating tablet per day for 4 weeks. If your symptoms do not improve in 4 weeks, consult your doctor.
Treatment of duodenal ulcer:one 30 mg orally disintegrating tablet per day for 2 weeks.
Treatment of gastric ulcer:one 30 mg orally disintegrating tablet per day for 4 weeks.
Treatment of esophagus inflammation (reflux esophagitis):one 30 mg orally disintegrating tablet per day for 4 weeks.
Long-term prevention of reflux esophagitis:one 15 mg orally disintegrating tablet per day, your doctor may adjust your dose to one 30 mg orally disintegrating tablet per day.
Treatment of Helicobacter pylori infection:the usual dose is one 30 mg orally disintegrating tablet in combination with two different antibiotics in the morning and one 30 mg orally disintegrating tablet in combination with two different antibiotics in the evening. The treatment will usually be for 7 days.
The recommended combinations of antibiotics are as follows:
If you are receiving treatment for an infection because you have an ulcer, it is unlikely that the ulcer will return if the infection is successfully treated. For your medicine to have the greatest chance of working, take it at the right time and do not forget any dose.
Treatment of duodenal or gastric ulcers in patients who require continuous treatment with NSAIDs:one 30 mg orally disintegrating tablet per day for 4 weeks.
Prevention of duodenal or gastric ulcers in patients who require continuous treatment with NSAIDs:one 15 mg orally disintegrating tablet per day, your doctor may adjust your dose to one 30 mg orally disintegrating tablet per day.
Zollinger-Ellison syndrome:The usual dose is two 30 mg orally disintegrating tablets per day to start, then, depending on how you respond to lansoprazole, the dose that your doctor decides is best for you.
Use in children
Lansoprazole should not be administered to children.
How to take
1- Hold the blister strip by the edges and separate one blister cell from the rest of the strip by gently tearing along the perforations that surround it.
2- Carefully remove the packaging.
3- Gently push the tablet out.
4- Place the tablet in your mouth. It will dissolve directly in your mouth, so you can swallow it easily.
In case of difficulty swallowing
Your doctor may indicate that you should take the tablet dissolved in a syringe, in case you have severe difficulty swallowing.
The following instructions should be followed if administered with a syringe:
It is important to carefully check the suitability of the selected syringe.
If you use a nasogastric tube:
It is important to carefully check the suitability of the selected tube.
The recommended diameter of the nasogastric tube to be used is 3.3 mm (size 10 French) or larger.
If you take more Lansoprazole Sun than you should
If you take more lansoprazole than you have been told, seek medical attention immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Lansoprazole Sun
If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose. If this happens, omit the missed dose and take the rest of the orally disintegrating tablets as usual. Do not take a double dose to make up for missed doses.
If you stop taking Lansoprazole Sun
Do not stop treatment early because your symptoms have improved. It is possible that your condition has not been completely cured and may return if you do not complete the treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you think you may have any of the following serious adverse effects, stop taking this medicine and contact your doctor or go immediately to the emergency room of the nearest hospital.
Other possible adverse effects:
Frequent:may affect up to 1 in 10 people:
Uncommon:may affect up to 1 in 100 people:
Rare:may affect up to 1 in 1,000 people:
Very rare:may affect up to 1 in 10,000 people:
Unknown frequency:cannot be estimated from the available data.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and on the box after "CAD". The expiration date is the last day of the month indicated.
Do not store above 30°C.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and unused medicines in the SIGRE collection point at the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and unused medicines. This way, you will help protect the environment.
Composition of Lansoprazol Sun
Each orodispersible tablet contains 15 mg of lansoprazole.
Each orodispersible tablet contains 30 mg of lansoprazole.
Appearance of the product and package contents
Lansoprazol Sun 15 mg are white to off-white round tablets, 9 mm in diameter, with orange to dark brown speckles and engraved with '15' on one side and smooth on the other.
Lansoprazol Sun 30 mg are white to off-white round tablets, 12 mm in diameter, with orange to dark brown speckles and engraved with '30' on one side and smooth on the other.
Lansoprazol Sun 15 mg orodispersible tablets are packaged in precut unit-dose blisters (AL/HDPE/PE with desiccant (attached to the foil) calcium oxide in OPA/AL/HDPE/PE film), in a pack size containing 14x1, 28x1, 56x1, 98x1 orodispersible tablets.
Lansoprazol Sun 30 mg orodispersible tablets are packaged in precut unit-dose blisters (AL/HDPE/PE with desiccant (attached to the foil) calcium oxide in OPA/AL/HDPE/PE film), in a pack size containing 14x1, 28x1, 56x1, 98x1 orodispersible tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
O
Terapia S.A.
124 Fabricii Street
400 632 Cluj Napoca,
Romania
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Sun Pharma Laboratorios, S.L.
Rambla de Catalunya 53-55
08007 Barcelona
Spain
This medicine is authorized in the Member States of the European Economic Area under the following names:
Spain: Lansoprazol SUN 15 mg orodispersible tablets EFG
Lansoprazol SUN 30 mg orodispersible tablets EFG
France: Lansoprazol SUN 15 mg orodispersible tablet
Lansoprazol SUN 30 mg orodispersible tablet
Italy: Lansoprazolo SUN Pharma
Sweden: Lansoprazole SUN pharma 15 mg orodispersible tablet
Lansoprazole SUN pharma 30 mg orodispersible tablet
Date of the last revision of this prospectus:September 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.